Literature DB >> 17705153

On the volume of distribution at steady state and its relationship with two-compartmental models.

James W T Yates1, Philip A Arundel.   

Abstract

The volume of distribution at steady state is considered to be one of the primary pharmacokinetic measurements obtained from in vivo experiments. This quantity is quite commonly calculated using moments of the observed concentration curve, the process being referred to as noncompartmental analysis. In this paper the underlying assumptions of noncompartmental analysis are analysed with regard to the observed behaviour of models with two compartments: one of which has elimination from the central compartment, the other from the peripheral tissue compartment. This is in order to clarify the relationship between volume of distribution and clearance. It is shown that these two models are indistinguishable from measurements in blood. Furthermore relationships between the parameter values for the two models are given so that they produce the same observed profile. Expressions are derived in a novel way that relates the volume of distribution to these model rate constants. The definitions of clearance and volume of distribution at steady state are investigated using several different mathematical techniques, demonstrating the consistency of the derived expressions. It is shown, in a manner that the authors believe is a new approach, that when the assumption of central elimination does not apply, noncompartmental analysis will under estimate the volume of distribution, whereas clearance remains unchanged. This is compared quantitatively with respect to the volume predicted where central elimination holds, and is a result of an extended mean residence time. (c) 2007 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  2008        PMID: 17705153     DOI: 10.1002/jps.21089

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Lumping of physiologically-based pharmacokinetic models and a mechanistic derivation of classical compartmental models.

Authors:  Sabine Pilari; Wilhelm Huisinga
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-07-27       Impact factor: 2.745

2.  Potential errors in the volume of distribution estimation of therapeutic proteins composed of differently cleared components.

Authors:  Wolfgang F Richter; Hans Peter Grimm; Frank-Peter Theil
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-07-21       Impact factor: 2.745

Review 3.  Pharmacokinetics of recombinant bifunctional fusion proteins.

Authors:  Xiaoying Chen; Jennica L Zaro; Wei-Chiang Shen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-03-20       Impact factor: 4.481

Review 4.  Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies.

Authors:  Miroslav Dostalek; Iain Gardner; Brian M Gurbaxani; Rachel H Rose; Manoranjenni Chetty
Journal:  Clin Pharmacokinet       Date:  2013-02       Impact factor: 6.447

5.  In vivo-formed versus preformed metabolite kinetics of trans-resveratrol-3-sulfate and trans-resveratrol-3-glucuronide.

Authors:  Satish Sharan; Otito F Iwuchukwu; Daniel J Canney; Cheryl L Zimmerman; Swati Nagar
Journal:  Drug Metab Dispos       Date:  2012-07-17       Impact factor: 3.922

6.  Steady-state volume of distribution of two-compartment models with simultaneous linear and saturated elimination.

Authors:  Xiaotian Wu; Fahima Nekka; Jun Li
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-07-12       Impact factor: 2.745

7.  Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 years.

Authors:  Francesco Bellanti; Giovanni C Del Vecchio; Maria C Putti; Aurelio Maggio; Aldo Filosa; Carlo Cosmi; Laura Mangiarini; Michael Spino; John Connelly; Adriana Ceci; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2016-11-06       Impact factor: 4.335

Review 8.  Effects of drug transporters on volume of distribution.

Authors:  Anita Grover; Leslie Z Benet
Journal:  AAPS J       Date:  2009-04-28       Impact factor: 4.009

9.  Mechanistic basis of post-treatment control of SIV after anti-α4β7 antibody therapy.

Authors:  Chad R Wells; Youfang Cao; David P Durham; Siddappa N Byrareddy; Aftab A Ansari; Nancy H Ruddle; Jeffrey P Townsend; Alison P Galvani; Alan S Perelson
Journal:  PLoS Comput Biol       Date:  2021-06-09       Impact factor: 4.475

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.